On 15-16 October 2025 RegMed XB welcomed the Nakanoshima Qross Delegation from Japan. Nakanoshima Qross is a translational hub for Regenerative Medicine based in Osaka.

Save the Date! Join us for an exciting community event on June 10th and 11th, covering the entire spectrum of regenerative medicine, from cutting-edge research to practical solutions.

DCVA (Dutch Cardiovascular Alliance), RegMed XB, BioGeneration Ventures (BGV) and its fund FIRST proudly announce that their joint Thematic Tech Transfer (TTT) program has been awarded €10 million in funding by the Netherlands Enterprise Agency (RVO), on behalf of the Ministry of Economic Affairs.